540222:BOM
Laurus Labs Ltd
2.059,00 INR
arrow_upward
+1,93%(+39,00) 1 d
16 oct, 15:59:49 GMT+5:30 · INR
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de 540222...
Abrir
2.027,35 INR
Alto
2.086,00 INR
Bajo
2.027,35 INR
Cap. burs.
1,11 B
Vol. medio
84,29 mil
Volumen
103,13 mil
Dividendo
0,10 %
Dividendo trimestral
0,50 INR
Fecha exdividendo
8 may 2026
Ratio PER
101,80
Máximo en 52 sem.
2.086,00 INR
Mínimo en 52 sem.
870,05 INR
BPA
20,23 INR
Acciones en circulación
106,44 M
N.º de empleados
7 mil
Abrir
2.027,35 INR
Alto
2.086,00 INR
Bajo
2.027,35 INR
Cap. burs.
1,11 B
Vol. medio
84,29 mil
Volumen
103,13 mil
Dividendo
0,10 %
Dividendo trimestral
0,50 INR
Fecha exdividendo
8 may 2026
Ratio PER
101,80
Máximo en 52 sem.
2.086,00 INR
Mínimo en 52 sem.
870,05 INR
BPA
20,23 INR
Acciones en circulación
106,44 M
N.º de empleados
7 mil
Noticias
De fuentes web y partners de noticias
The Economic Times
·
hace 4 horas
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
TipRanks
·
hace 3 días
Laurus Labs schedules Q2 and H1 FY27 earnings call for October 29
Perfil
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Acerca de Laurus Labs Ltd